HP
Hikari Power Portfolio holdings
AUM
$1.2B
This Quarter Return
+2.3%
1 Year Return
+14.18%
3 Year Return
+56.59%
5 Year Return
+122.08%
10 Year Return
+191.59%
AUM
$741M
AUM Growth
+$741M
(+5.5%)
Cap. Flow
+$33.9M
Cap. Flow
% of AUM
4.57%
Top 10 Holdings %
Top 10 Hldgs %
60.64%
Holding
104
New
35
Increased
22
Reduced
3
Closed
10
Top Buys
| 1 |
Wabtec
WAB
|
$13.5M |
| 2 |
Waters Corp
WAT
|
$9.52M |
| 3 |
Gilead Sciences
GILD
|
$5.49M |
| 4 |
DO
Diamond Offshore Drilling
DO
|
$4.96M |
| 5 |
RTX Corp
RTX
|
$4.95M |
Top Sells
| 1 |
IBM
IBM
|
$27.3M |
| 2 |
Cisco
CSCO
|
$2.23M |
| 3 |
United Therapeutics
UTHR
|
$1.09M |
| 4 |
Ligand Pharmaceuticals
LGND
|
$1.06M |
| 5 |
DBVT
DBV Technologies
DBVT
|
$1.03M |
Sector Composition
| 1 | Financials | 38.94% |
| 2 | Healthcare | 24.52% |
| 3 | Industrials | 11.96% |
| 4 | Technology | 10.74% |
| 5 | Energy | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.09T
| $178M | 24.01% | 699 | – | – |
|
2
Wells Fargo
WFC
$263B
| $85.6M | 11.54% | 1,544,420 | – | – |
|
|
3
IBM
IBM
$227B
| $46.2M | 6.23% | 300,200 -177,200 | -37% | -$27.3M |
|
4
3M
MMM
$82.8B
| $23.2M | 3.13% | 111,400 | – | – |
|
5
Johnson & Johnson
JNJ
$427B
| $22.7M | 3.07% | 171,900 | – | – |
|
|
PX
6
DELISTED
Praxair Inc
PX
| $20M | 2.7% | 151,020 | – | – |
|
|
7
RTX Corp
RTX
$212B
| $18.8M | 2.53% | 153,700 +40,500 | +36% | +$4.95M |
|
8
DaVita
DVA
$9.85B
| $18.7M | 2.52% | 288,900 | – | – |
|
9
Danaher
DHR
$147B
| $18.2M | 2.46% | 215,800 +5,400 | +3% | +$456K |
|
10
Novo Nordisk
NVO
$251B
| $18.2M | 2.45% | 423,800 | – | – |
|
11
Phillips 66
PSX
$54B
| $17.8M | 2.41% | 215,700 +11,400 | +6% | +$943K |
|
|
AGN
12
DELISTED
Allergan plc
AGN
| $17.4M | 2.34% | 71,400 | – | – |
|
13
Roper Technologies
ROP
$56.6B
| $16.3M | 2.2% | 70,600 | – | – |
|
14
Visa
V
$683B
| $16.1M | 2.17% | 171,900 | – | – |
|
|
15
Wabtec
WAB
$33.1B
| $15.7M | 2.11% | 171,200 +147,500 | +622% | +$13.5M |
|
16
Boeing
BA
$177B
| $15M | 2.02% | 75,900 | – | – |
|
|
POT
17
DELISTED
Potash Corp Of Saskatchewan
POT
| $13.6M | 1.84% | 836,200 +107,700 | +15% | +$1.76M |
|
|
SRCL
18
DELISTED
Stericycle Inc
SRCL
| $9.92M | 1.34% | 130,000 | – | – |
|
19
NOV
NOV
$4.94B
| $9.67M | 1.3% | 293,400 +28,100 | +11% | +$926K |
|
|
20
Waters Corp
WAT
$18B
| $9.52M | 1.28% | +51,800 | New | +$9.52M |
|
|
21
Gilead Sciences
GILD
$140B
| $9.15M | 1.23% | 129,330 +77,630 | +150% | +$5.49M |
|
22
Fortive
FTV
$16.2B
| $8.98M | 1.21% | 141,700 +36,500 | +35% | +$2.31M |
|
23
Sanofi
SNY
$121B
| $8.21M | 1.11% | 171,300 | – | – |
|
|
CELG
24
DELISTED
Celgene Corp
CELG
| $7.46M | 1.01% | 57,400 | – | – |
|
25
Amgen
AMGN
$155B
| $7.35M | 0.99% | 42,700 +1,200 | +3% | +$207K |
|